ArticleAnnual review of clinical psychology2018
Transforming the Treatment of Schizophrenia in the United States: The RAISE Initiative.
Article in Annual review of clinical psychology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02069925 (STEP-ED), which is not on this map. Cited by 49 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
STEP-ED: Reducing Duration of Untreated Psychosis and Its Impact in the U.S.
Who cites it
49 citing papers in PubMed, 106 citations in OpenAlex.
- The impact of Duration of Untreated Psychosis on functioning and quality of life over one year of Coordinated Specialty Care (CSC).PloS one · 2025Trial
- Hippocampal Subfield Volumes Predict Disengagement from Maintenance Treatment in First Episode Schizophrenia.Schizophrenia bulletin · 2023Trial
- Cognitive Enhancement Therapy vs social skills training in schizophrenia: a cluster randomized comparative effectiveness evaluation.BMC psychiatry · 2022Trial
- "No tears or brain words": A case report on single-session dance/movement therapy for individuals with schizophrenia spectrum disorders.BMC complementary medicine and therapies · 2026Article
- Opportunities for Digital Health to Support Early Psychosis Care in Ghana: Qualitative Study Among Patients, Caregivers, and Clinicians.JMIR formative research · 2026Article
- A pilot study of BRAVE, a CBT intervention to reduce violence risk in early psychosis.Cognitive behaviour therapist · 2026Article
- The EnTRy Program: Expanding Coordinated Specialty Care Beyond Early Psychosis.Community mental health journal · 2025Article
- Behind the Gaps: A Narrative Review of Healthcare Barriers for Individuals with Serious Mental Illness.Healthcare (Basel, Switzerland) · 2025Review
- Social cognition as a mediator between neurocognition and functional outcome in early course schizophrenia.Psychiatry research · 2025Article
- The STEP Learning Collaborative: A statewide Learning Healthcare System (LHS) for first episode psychosis.Schizophrenia research · 2025Article
- Connection Learning Healthcare System Hub of the Early Psychosis Intervention Network: Program and Participant Characteristics.Early intervention in psychiatry · 2025Article
- Forging a learning health system for early psychosis: Insights from the academic community EPINET.Schizophrenia research · 2025Article
- The Academic Community Early Psychosis Intervention Network: Toward building a novel learning health system across six US states.Learning health systems · 2025Article
- Building a two-state learning healthcare system for persons with first episode psychosis.Schizophrenia research · 2025Article
- Digital health for early psychosis in Ghana: patient and caregiver needs and preferences.Schizophrenia (Heidelberg, Germany) · 2025Article
- Qualitative Evaluation of Acceptability and Feasibility of a Behavioral Intervention to Reduce Violence Among Young Adults with Early Psychosis.Community mental health journal · 2025Article
- An open pilot trial of a behavioural intervention to reduce violence by young adults with early psychosis receiving treatment in an early intervention services setting: A protocol.Early intervention in psychiatry · 2024Article
- Prevalence of schizophrenia spectrum disorders in the Lazio region, Italy: use of an algorithm based on health administrative databases.BMC psychiatry · 2024Article
- The influence of complex psychiatric comorbidities on treatment for clinical high-risk for psychosis: A preliminary study.Early intervention in psychiatry · 2024Article
- One-Year Medication Treatment Patterns, Healthcare Resource Utilization, and Expenditures for Medicaid Patients with Schizophrenia Starting Oral Atypical Antipsychotic Medication.Administration and policy in mental health · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 4 institutions in 1 country.
Funding
Abstract
The schizophrenia spectrum disorders are neurodevelopmental illnesses with a lifetime prevalence near 1%, producing extensive functional impairment and low expectations for recovery. Until recently, treatment in the United States has largely attempted to stabilize individuals with chronic schizophrenia. The identification and promotion of evidence-based practices for schizophrenia via the Patient Outcomes Research Team, combined with international studies supporting the value of early intervention, provided the foundation for the Recovery After an Initial Schizophrenia Episode (RAISE) project. The RAISE studies further supported the value of reducing the duration of untreated psychosis and providing a multi-element treatment called coordinated specialty care (CSC) to improve outcomes for patients in usual treatment settings. Although CSC programs have proliferated rapidly in the United States, many challenges remain in the treatment and recovery of individuals with schizophrenia in the aftermath of RAISE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.